PR Newswire (press release)MilliporeSigma Brings Customers Closer to Gene Therapy Product CommercializationPR Newswire (press release)BURLINGTON, Mass., Oct. 19, 2017 /PRNewswire/ — MilliporeSigma today announced that its Carlsbad, California-based ma… Continue reading
Financial TimesGene therapy helped these children see. Can it transform medicine?Financial TimesOver home-made brownies and iced tea, Caroline and Cole tell me how they received a pioneering treatment known as gene therapy on a clinical trial in 2014, … Continue reading
KCTV Kansas City |
Tooth banking: Is the next wave in stem cell treatment right for you?
KCTV Kansas City For example, if your child or family member turned up with some sort of blood cancer, which is a common reason to turn to stem cell storage, Burgert says you won’t get any help from banked teeth. “Those stem cells that can be extracted from teeth are … |
Philadelphia Business Journal |
FDA approves second gene-altering treatment for cancer
Philadelphia Business Journal The treatment, considered a form of gene therapy, transforms the patient’s cells into what researchers call a “living drug” that attacks cancer cells. It is part of the rapidly growing field of immunotherapy, which uses drugs or genetic tinkering to … US approves second gene therapy against cancerDeathRattleSports.com |
|
City of Hope, Leading Cancer Research and Treatment Center, to Provide First-Ever FDA-Approved CAR–T Cell …
Business Wire (press release) Axicabtagene ciloleucel, a Kite Pharma Inc. product, is a therapy in which a patient’s T cells are engineered to express a chimeric antigen receptor (CAR) to target the antigen CD19, a protein found on the cell surface of NHL as well as other lymphoma … |